Calcium- and Cell Cycle-dependent Association of Annexin 11 with the Nuclear Envelope*

Alejandra Tomas and Stephen E. Moss {ddagger}

From the Division of Cell Biology, Institute of Ophthalmology, 11-43 Bath Street, London EC1V 9EL, United Kingdom

Received for publication, December 12, 2002 , and in revised form, February 21, 2003.
    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Annexin 11 is a widely expressed calcium- and phospholipid-binding protein that resides in the nucleoplasm in many cultured cell lines. This is in contrast to its most extensively characterized in vitro ligand, the small calcium-binding protein S100A6 (calcyclin), which is concentrated in the nuclear envelope. Here we have examined the significance of the association of annexin 11 and S100A6 by asking whether circumstances exist in which the two proteins occupy the same subcellular localization. First, we show that in both A431 and vascular smooth muscle cells, elevation of intracellular Ca2+ leads to translocation of annexin 11 from the nucleus to the nuclear envelope where it co-localizes with S100A6. We also demonstrate, using fusions of annexin 11 with green fluorescent protein, that whereas the C-terminal core domain of annexin 11 is essential for Ca2+ sensitivity, the N-terminal domain is required for targeting to the nuclear envelope. Second, we show that annexin 11 relocalizes to the nuclear envelope as A431 cells transit from early to mid-prophase. In late prophase, at the time of nuclear envelope breakdown, annexin 11 and S100A6 become intensely localized with lamina-associated polypeptide 2 to folds in the nuclear envelope. From metaphase to telophase S100A6 is degraded, but in late telophase annexin 11 associates with the reforming nuclear envelope before resuming a nucleoplasmic location in interphase. These results show that co-localization of annexin 11 and S100A6 at the nuclear envelope may be regulated either by elevation of intracellular Ca2+ or by cell cycle progression and provide the first evidence that these proteins may associate in vivo.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
The vertebrate annexins constitute a family of 12 distinct genes that encode proteins with the shared ability to bind calcium dependently to negatively charged phospholipids (for reviews see Refs. 1 and 2). Despite their considerable structural similarity and overlapping biophysical characteristics, research in recent years indicates that individual annexins have distinct physiological roles. Thus, although annexin function is still not understood at the mechanistic level, targeted gene disruption experiments in mice and chick DT40 cells have revealed a range of phenotypes that are generally unaccompanied by compensatory changes in expression of other annexins. These phenotypes point to roles for annexins in diverse biological processes, including vesicle trafficking (3, 4), calcium signaling (5, 6), and lipid raft organization (7, 8).

For several annexins it is clear they do not act alone. Annexin 2 was first isolated as a component of a stable heterotetrameric complex with S100A10 (formerly p11) (9). S100 proteins form a branch of the EF-hand Ca2+-binding proteins exemplified by calmodulin and constitute a second family of calcium-binding proteins of poorly understood functions (10). The (annexin 2·S100A10)2 complex is unusual in being calcium-independent. This is because the two EF-hands of S100A10 contain amino acid changes that render the canonical helix-loop-helix incapable of binding calcium ions while driving structural changes that effectively lock S100A10 into a form that mimics a hypothetical Ca2+-bound structure (11). Although the complex is stable in the absence of Ca2+, the two annexin 2 monomers within the complex retain Ca2+ sensitivity, rendering the quaternary protein complex potentially sensitive to changes in intracellular Ca2+ concentration.

Interactions between annexins and S100 proteins are now known to extend to other members of these protein families. Annexin 1 binds to S100A11 (formerly S100C) (12, 13) and annexin 11 binds to S100A6 (formerly calcyclin) (14). In contrast to the annexin 2·S100A10 complex, interactions between annexins 1 and 11 and their respective S100 ligands are absolutely dependent on Ca2+. For this reason, it has so far proven impossible to isolate the Ca2+-dependent annexin·S100 complexes from cell or tissue extracts. The discovery that annexin 11 binds to S100A6 was the result of affinity chromatography using immobilized S100A6 (15). A reverse strategy, in which the immobilized N terminus of annexin 1 was used as bait in A431 cell extracts, led to the discovery of S100A11 as a cognate binding partner (12). Given the specificity of the annexin 1-S100A11 and annexin 11-S100A6 interactions and the relatively low Ca2+ requirement for their formation, it is reasonable to expect that under certain circumstances these complexes may exist in living cells. Indeed, mutation of the binding site for annexin 1 on S100A11 results in failure of S100A11 to be recruited to transferrin receptor-positive endosomes, indicating that this interaction does indeed occur in vivo (16).

Despite several studies on the interaction between annexin 11 and S100A6, including identification of the binding site to residues 49-62 in the long N-terminal domain (17), the mutual exclusion of the two proteins from a single subcellular compartment raises the possibility that the annexin 11·S100A6 complex may exist only in vitro. Because annexin 11 and S100A6 are both Ca2+-binding proteins and because S100A6 protein levels oscillate in a cell cycle-dependent manner (18), we therefore examined whether Ca2+ fluxes and/or cell cycle progression might regulate the co-localization of annexin 11 and S100A6. We show here that, whereas S100A6 is relatively sedentary in the nuclear envelope, annexin 11 interacts dynamically with the nuclear envelope in both a Ca2+- and cell cycle-dependent manner. These results support the idea of a functional relationship between annexin 11 and S100A6.


    EXPERIMENTAL PROCEDURES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Cell Culture Conditions—A431 cells were grown in Dulbecco's modified Eagle's medium (Invitrogen) supplemented with 10% (v/v) fetal calf serum, 100 units/ml penicillin, 100 µg/ml streptomycin, and 292 µg/ml L-glutamine at 37 °C in 5% CO2-humidified incubators. Cells were kept subconfluent, and the medium was changed every 2 to 3 days. Pig vascular smooth muscle cells (VSMC),1 generously provided by Dr. Y. Hong (University College London, UK), were cultured in Dulbecco's modified Eagle's medium supplemented with 20% (v/v) fetal calf serum, 100 units/ml penicillin, 100 µg/ml streptomycin, and 292 µg/ml L-glutamine. For live cell microscopy, cells were grown in 35-mm glass bottom microwell dishes (MatTek).

Antibodies and Growth Factors—Primary antibodies for immunofluorescence were L-19 goat polyclonal anti-human annexin 11 (Santa Cruz Biotechnology), mouse monoclonal anti-pig S100A6 (Sigma), M-20 goat polyclonal anti-mouse lamin B (Santa Cruz Biotechnology), and mouse monoclonal anti-rat lamina-associated polypeptide 2 (LAP2) (Transduction Laboratories). Secondary antibodies were donkey anti-goat-Alexa Fluor 488 (Molecular Probes), donkey anti-mouse-Cy5, and donkey anti-mouse-TRITC (gift from Dr. C. Futter, Institute of Opthalmology, University College London, UK). Antibodies for Western blotting were affinity-purified sheep polyclonal anti-chicken annexin 11 (raised against recombinant chicken annexin 11 protein) and 4G10 mouse monoclonal anti-phosphotyrosine (Upstate Biotechnology). Epidermal growth factor (EGF), a gift from Dr. A. Limb (University College London, UK), was used at 40 ng/ml, and platelet-derived growth factor BB (PDGF-BB), a gift from Dr. M. Bailly (University College London, UK), was used at 50 ng/ml.

Immunofluorescence Microscopy—Cells were washed in PBS, fixed/permeabilized on ice for 30 min in 2% paraformaldehyde + 0.1% Triton X-100, washed four times in PBS and blocked for 15 min with 1% BSA (Sigma). Fixed cells were then incubated in a moist chamber with primary antibody in 1% BSA for 1 h, followed by four washes of 5-10 min each in PBS before incubation with the secondary antibody in 1% BSA for another hour. After four more washes in PBS, samples were observed under a Bio-Rad Radiance 2000 AGR 3 (Q) confocal attached to a Zeiss Axiovert S100TV inverted microscope using a x100 oil immersion lens. Images were acquired with LaserSharp 2000 (Bio-Rad) and processed using Metamorph 4.6r9 (Universal Imaging).

Immunoprecipitation, SDS-PAGE, and Western Blotting—A431 cell monolayers were washed in PBS, solubilized in 500 µl of lysis buffer (50 mM Tris-HCl, pH 7.4, 50 mM NaCl, 30 mM sodium pyrophosphate, 50 mM sodium fluoride, 100 µM sodium orthovanadate, 0.2 mM CaCl2, 1% Triton X-100, 0.1% BSA, 0.02% sodium azide) supplemented with 10 µl of protease inhibitor mixture (Sigma) per 107 cells and lysed by three rounds of sonication on ice. Lysates were precleared at 16,000 g for 30 min at 4 °C, followed by incubation with 30 µl of 50% Protein G-Sepharose 4 fast flow slurry (Amersham Biosciences) for 30 min, and then 5 min of centrifugation at 16,000 g at 4 °C. L-19 goat anti-human annexin 11 antibody (Santa Cruz Biotechnology) was immobilized on Protein G-Sepharose beads and added to the precleared lysates for 2 h at 4 °C and centrifuged, and the supernatant discarded. Beads were washed four times in lysis buffer minus BSA and once in ice-cold PBS. After removal of the supernatant, immunoprecipitates were resuspended in SDS-PAGE sample buffer, boiled for 5 min, and resolved by SDS-polyacrylamide gel electrophoresis on discontinuous mini-gels. Proteins were electroblotted for 45 min at 400 mA onto Hybond-P polyvinylidene difluoride transfer membrane (Amersham Biosciences).

Membranes were treated with blocking solution (10% skimmed milk or 10% BSA in PBS-Tween (PBS + 0.05% Tween 20)) for 40 min at room temperature and incubated for 16 h at 4 °C with primary antibody in PBS-Tween. Following three PBS-Tween washes, membranes were incubated with secondary antibody for 90 min, also in PBS-Tween (1/10,000 dilution). IgG-horseradish peroxidase conjugates were used as secondary antibodies. Blots were developed after three more PBS-Tween washes using the ECL Plus Western blotting detection system (Amersham Biosciences) and visualized in a Fujifilm Intelligent Dark Box II coupled to a LAS-1000 charge coupled device-camera.

Generation of Annexin 11·Green Fluorescent Protein (GFP) Fusion Constructs—Full-length human annexin 11 coding sequence, annexin 11 N-terminal domain (nucleotides 1-642 in the annexin 11 coding sequence), and annexin 11 C-terminal core domain (nucleotides 624-1515 in the annexin 11 coding sequence) were amplified by RT-PCR from A431 cDNA and cloned in-frame into pEGFP-C3 vector (Clontech) for fusion at the C-terminal end of GFP or into pEGFP-N3 vector (Clontech) for fusion at the N-terminal end of GFP.

Transient Transfection and Live Cell Imaging—Cells were transfected with the different annexin 11·GFP fusion constructs using LipofectAMINE 2000 reagent (Invitrogen) following the manufacturer's instructions and incubated for 24 h to allow gene expression before placing them in a 37 °C preheated microscope chamber with 5% CO2 supply. Cells were observed before and after stimulation under a Bio-Rad Radiance 2000 AGR-3 (Q) confocal attached to a Zeiss Axiovert S100TV inverted microscope using a x100 oil immersion lens. Images were acquired with LaserSharp 2000 (Bio-Rad) and analyzed using Metamorph 4.6r9 (Universal Imaging).

Cell Synchronization—Cells were grown to 50% confluence and incubated overnight in medium containing 4 mM thymidine (Sigma) to achieve S phase block. Dishes were extensively washed in PBS and cultured for a further 6 h in medium containing 0.07 µg/ml nocodazole (Sigma) for growth arrest at the onset of mitosis. Cells were then extensively washed and allowed to recover in normal medium for 5-60 min before immunofluorescence analysis.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
We first examined the subcellular localization of annexin 11 and S100A6 in fixed A431 epidermoid carcinoma cells. Annexin 11 was predominantly nuclear, though excluded from the nucleoli, and was also apparent in punctate form in the cell cytoplasm (Fig. 1A). In contrast, S100A6 displayed a strong signal in the region of the nuclear envelope, together with discrete inner nuclear structures and punctate cytoplasmic staining that did not coincide with annexin 11. Thus, in unstimulated A431 cells, S100A6 and annexin 11 appear to occupy non-overlapping subcellular compartments. Similar results were obtained in HeLa and HEp2 cells (data not shown). To confirm that the S100A6-positive ring-like structure at the nuclear periphery is the nuclear envelope, A431 cells were co-stained for lamin B, a well characterized resident of the inner nuclear membrane (Fig. 1B). The results show that S100A6 is indeed strongly enriched at the nuclear envelope and also co-localizes with lamin B at focal points within the nucleus. The constitutive association of S100A6 with the nuclear envelope in A431 cells contrasts with previous studies in vascular smooth muscle cells in which this interaction was reported to be Ca2+-dependent (19).



View larger version (33K):
[in this window]
[in a new window]
 
FIG. 1.
Annexin 11 and S100A6 reside in distinct subcellular compartments in unstimulated A431 cells. A, untreated A431 cells were fixed and stained for annexin 11, S100A6, and DNA (with propidium iodide). Annexin 11 concentrates at the cell nucleoplasm and is excluded from the nucleoli and the nuclear envelope, whereas the fluorescent signal for S100A6 concentrates mainly at the nuclear envelope. B, untreated A431 cells were fixed and stained for S100A6, the inner nuclear envelope protein lamin B, and DNA. S100A6 strongly co-localizes with lamin B at the nuclear envelope of A431 cells.

 

To investigate the Ca2+ sensitivity of S100A6 and annexin 11 in our experimental model, A431 cells were exposed to ionomycin for 30 min prior to fixation and immunostaining (Fig. 2A). Elevation of intracellular Ca2+ caused the relocalization of annexin 11 to the nuclear envelope but had little effect on either S100A6 or the punctate cytoplasmic pool of annexin 11. Because annexin 11 has been reported to be a substrate for cellular protein kinases, including the calcium-activated tyrosine kinase Pyk2 (20, 21), we also examined whether the response to ionomycin was accompanied by protein phosphorylation (Fig. 2B). Immunoprecipitation of annexin 11 from ionomycin-treated cells, followed by Western blotting with an anti-phosphotyrosine antibody, revealed that annexin 11 is indeed phosphorylated on tyrosine under these conditions. In contrast, neither staurosporine nor EGF treatment led to tyrosine phosphorylation of annexin 11, nor did either stimulus drive the association of annexin 11 to the nuclear envelope (not shown).



View larger version (47K):
[in this window]
[in a new window]
 
FIG. 2.
Annexin 11 relocates to the nuclear envelope in response to elevation of intracellular Ca2+ levels. A, A431 cells were stimulated for 30 min with 2.5 µM ionomycin in medium containing Ca2+ and subsequently fixed and stained for annexin 11 and S100A6. Annexin 11 partially relocates to the nuclear envelope under these conditions (green arrows), where it co-localizes with S100A6 (left panels). B, A431 cells were either stimulated with 2.5 µM ionomycin for 30 min, 1 µM staurosporine for 3 h, 40 ng/ml EGF for 15 min, or left untreated (control). Immune complexes were resolved by SDS-PAGE followed by Western blotting with an anti-phosphotyrosine antibody, and for annexin 11 to confirm equal loadings. C, A431 cells were exposed to ionomycin or buffer alone and extracted into lysis buffer containing either 200 µM CaCl2 or 5 mM EGTA. Samples were centrifuged, and annexin 11 was subsequently immunoprecipitated from both supernatant (Cyt) and resolubilized nuclear pellet (Nuc). Following SDS-PAGE and Western transfer, the membrane was immunoblotted first with an anti-phosphotyrosine antibody and then, after stripping the blot, with an antibody to annexin 11.

 

Because the lysis conditions used in these immunoprecipitation experiments favored a whole cell extraction, we next investigated the ionomycin-induced tyrosine phosphorylation of annexin 11 in cytosolic and nuclear extracts prepared in the absence and presence of 200 µM Ca2+ (Fig. 2C). These experiments demonstrate that preservation of tyrosine phosphorylation in lysates of ionomycin-treated A431 cells requires the presence of Ca2+ in the lysis buffer. Interestingly, separation of the nuclear and cytosolic pools led to the apparent partial degradation of tyrosine-phosphorylated annexin 11 in both fractions to polypeptide species of 30 and 40 kDa, respectively. However, reprobing the blot with antisera to annexin 11 shows that the majority of the protein remains in the 55-kDa form, suggesting that tyrosine phosphorylation of annexin 11 may increase its susceptibility to proteolysis.

Because studies elsewhere have shown that annexin 11 can also be tyrosine-phosphorylated in activated VSMCs (21), we next examined whether the results obtained in A431 cells would be paralleled in VSMCs. In these experiments we performed live cell-image analysis to track the localization of an ectopically expressed annexin 11·GFP fusion protein in primary cultures of porcine VSMCs. A series of confocal images were obtained every 5 s for 3 min following exposure to ionomycin and clearly showed that annexin 11·GFP becomes tightly localized to the nuclear envelope as well as to both plasma membrane and dispersed intracellular structures within a few seconds of ionophore treatment (Fig. 3A). Treatment of VSMCs with PDGF-BB had no effect on the nuclear annexin 11·GFP but led to a concentration of cytoplasmic annexin 11·GFP partly to the plasma membrane and also to intracellular structures (Fig. 3B). The contrasting effects of ionophore and growth factor in VSMCs closely match the results obtained in A431 cells. Consistent with these findings, we observed a negligible effect of PDGF-BB on tyrosine phosphorylation of annexin 11 in stimulated VSMCs (Fig. 3C), whereas annexin 11 was clearly tyrosine-phosphorylated in ionomycin-treated cells.



View larger version (30K):
[in this window]
[in a new window]
 
FIG. 3.
Calcium-dependent relocalization of annexin 11 in vascular smooth muscle cells. A, porcine VSMCs were transiently transfected with annexin 11-GFP and then stimulated with 2.5 µM ionomycin while being imaged every 5 s on the heated stage of a confocal microscope. Selected images from the timed series are shown, revealing a rapid and striking translocation of annexin 11 to the nuclear envelope and various other intracellular membranes. B, VSMCs were transiently transfected with annexin 11·GFP and imaged as in panel A before and after the addition of 50 ng/ml PDGF-BB. The images show PDGF-dependent relocalization of cytosolic annexin 11·GFP to the plasma membrane and cytoplasmic vesicles. C, VSMCs were exposed to either 2.5 µM ionomycin or 50 ng/ml PDGF for 15 min or left untreated (control), and annexin 11 was immunoprecipitated from total cell extracts. Following SDS-PAGE and Western transfer, the blot was probed first with an antibody to phosphotyrosine and, after stripping, to an antibody to annexin 11 to confirm equal protein loadings.

 

Next, we investigated the structural basis for the annexin 11 response to ionomycin (Fig. 4). Two constructs were generated in which the full-length annexin 11 coding sequence was fused to GFP, one with GFP at the C terminus of annexin 11 (anx11·GFP) and the other with GFP at the N terminus (GFP·anx11). Two additional expression plasmids were constructed, one in which the four-repeat Ca2+-binding C terminus of annexin 11 was replaced with GFP (N-ter·GFP) and a second in which GFP replaced the long proline-, tyrosine- and glycine-rich N terminus (GFP·C-ter). Transient transfection of these constructs in A431 cells revealed that anx11·GFP and GFP·anx11 were expressed in both the nucleus and cytoplasm of living cells, with anx11·GFP tending to exhibit a greater enrichment in the nucleus. N-ter·GFP expression was markedly stronger in the nucleus than the cytoplasm, whereas GFP·C-ter was completely excluded from the nucleus. This is in agreement with previous observations that showed the N-terminal domain of annexin 11 is both necessary and sufficient for the nuclear localization of annexin 11 (22).



View larger version (60K):
[in this window]
[in a new window]
 
FIG. 4.
Live cell imaging of annexin 11·GFP fusions in A431 cells. A431 cells were transiently transfected with full-length human annexin 11 coding sequence fused to GFP either at the C terminus (anx11·GFP) or at the N terminus (GFP·anx11), with the annexin 11 proline-, tyrosine-, and glycine-rich (PYG) N-terminal domain fused to GFP (N-ter·GFP), or with the annexin 11 C-terminal core domain fused to GFP (GFP·C-ter). Cells expressing the fusion constructs were imaged before and after the addition of 2.5 µM ionomycin, both in Ca2+-containing and Ca2+-free external medium. After stimulation with ionomycin, the full-length annexin 11 fusion proteins relocate primarily to the nuclear envelope (pink arrowheads) and can also be detected with a punctate pattern at the cytoplasm/plasma-membrane, whereas the fusion protein containing the annexin 11 N-terminal domain does not respond to ionomycin treatment. The annexin 11 C-terminal core domain containing the four conserved annexin repeats relocates to intracellular membranes but not the nuclear envelope. These changes in localization occur both in the presence and absence of external Ca2+ (pink/yellow arrowheads), suggesting that mobilization of Ca2+ from intracellular stores is sufficient to elicit this response.

 

We then compared the responses of these expression constructs to ionomycin treatment in the presence and absence of extracellular Ca2+. Both anx11·GFP and GFP·anx11 displayed almost complete relocalization from the nucleus to the nuclear envelope, together with a change from diffuse cytoplasmic fluorescence to punctate cytoplasmic or plasma membrane-associated fluorescence. Similar results were obtained regardless of the presence or absence of extracellular Ca2+, indicating that mobilization of Ca2+ from intracellular stores alone is sufficient to elicit these responses. In contrast, N-ter·GFP completely failed to respond to ionomycin, and although GFP·C-ter exhibited sensitivity to Ca2+ by relocating to intracellular membranes, there was no evidence of preferential translocation to the nuclear envelope. These results demonstrate that whereas the C-terminal core domain of annexin 11 is essential to confer Ca2+ sensitivity, the N-terminal domain determines the specificity for the nuclear envelope in the Ca2+-dependent relocalization of annexin 11. Furthermore, the images obtained using anx11·GFP and GFP·anx11 demonstrate that GFP may be fused to either end of the annexin 11 molecule without interfering with normal responses to changes in intracellular Ca2+ concentration.

Although these results reveal a potential mechanism whereby the annexin 11-S100A6 interaction might be regulated, we were interested to explore the possibility of a cell cycle-dependent interaction. In A431 cells at early prophase we obtained evidence in support of this idea (Fig. 5A). At this point in the cell cycle the nuclear pool of annexin 11 apparently relocates, at least in part, to the nuclear envelope. The annexin 11 remaining in the nucleus becomes distinct from the condensed DNA content, which contrasts with the picture obtained for interphase cells (Fig. 1A). We also observed, in cells further into prophase, that annexin 11 becomes associated with invaginations or folds in the nuclear envelope where it co-localizes with S100A6. The pattern of immunostaining for annexin 11 and S100A6 in these late prophase cells is similar to that reported for other nuclear envelope proteins, in particular LAP2 (23). We therefore co-stained late prophase cells for annexin 11 and LAP2 (Fig. 5B), which enabled us to confirm that annexin 11 is indeed associated with microtubule-induced folds that serve an initiating role in nuclear envelope breakdown (24).



View larger version (46K):
[in this window]
[in a new window]
 
FIG. 5.
Dynamic association of annexin 11 with the nuclear envelope during cell division. A431 cells were synchronized in mitosis, fixed, and stained for annexin 11, DNA, and S100A6 (A) or the inner nuclear membrane protein LAP2 (B) during prophase. Annexin 11 invades the nuclear envelope at discrete foci in early prophase (panel A, pink arrowheads) and concentrates at folds in the nuclear envelope where it colocalizes with S100A6 (panel A, yellow arrowheads) and with LAP2 (panel B, pink arrowheads). A431 cells were synchronized in mitosis, fixed, and stained for annexin 11, DNA, and LAP2. The images show cells engaged in nuclear envelope reassembly during late telophase and recently divided cells in early interphase (C). Annexin 11 is enriched at the nascent nuclear envelope of cells undergoing cytokinesis, together with LAP2 (top row, white arrowheads), before shuttling back into the nucleus where it resides during interphase (bottom row).

 

S100A6 immunostaining was virtually undetectable in A431 cells from metaphase to telophase (not shown), indicating that S100A6 protein levels drop during mitosis. This observation is in agreement with previous studies that showed the level of expression of S100A6 is regulated in a cell cycle-dependent manner, peaking in the transition from G0- to S-phase in smooth muscle cells (18). We therefore immunostained A431 cells in telophase for annexin 11 and LAP2 (Fig. 5C). In late telophase, annexin 11 and LAP2 again co-localize, this time in the reforming nuclear envelope. However, while LAP2 remains clearly associated with the nuclear envelope as cells progress into early interphase, annexin 11 becomes concentrated within the nucleus. These observations show that annexin 11 displays a dynamic and biphasic interaction with the nuclear envelope, first during nuclear envelope breakdown and again during reassembly of the nuclear envelope.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Annexin 11 is unusual within the annexin family in being a predominantly nuclear protein. This is in contrast to its most extensively characterized in vitro ligand, S100A6, which is shown here and in other studies (19) to be localized to the nuclear envelope. Because the annexin literature contains several unverified reports of interactions between annexins and putative intracellular ligands, it is important to establish which, if any, of these occur in vivo because such interactions are likely to have functional consequences. A more recently identified ligand of annexin 11, namely the penta-EF-hand protein ALG-2 (apoptosis-linked gene 2) (25) is expressed in the nucleus (26), though ALG-2 also binds annexin 7, peflin, and AIP1/Alix (25, 27). The binding site for ALG-2 on annexins 7 and 11 is located in the long PYG domain at the N terminus of each annexin, a domain that is also present in AIP1/Alix. Because the binding sites for ALG-2 and S100A6 on annexin 11 are therefore both located in the N terminus, these observations raise the possibility that, depending on subcellular localization and the availability of free Ca2+, S100A6 and ALG-2 may compete for and differentially modulate the properties of annexin 11. However, prior to consideration of these hypothetical possibilities it is necessary to establish a prerequisite for the annexin 11-S100A6 interaction, namely that the two proteins occupy a single subcellular compartment.

We show here that whereas annexin 11 and S100A6 are unlikely to interact in vivo in interphase cells under resting conditions, they are both present at the nuclear envelope upon elevation of intracellular calcium. Interestingly, despite the fact that annexin 11 and S100A6 are both Ca2+-binding proteins, annexin 11 alone manifested its Ca2+ sensitivity as a change in localization. Moreover, the N-terminal domain of annexin 11, known to contain the S100A6-binding site, was necessary for the relocalization of annexin 11 to the nuclear envelope in ionomycin-treated A431 cells, reinforcing the idea that the association of annexin 11 with the nuclear envelope in the presence of calcium may occur via a direct interaction with S100A6. The finding that ionomycin treatment leads not only to the relocalization of annexin 11 to the nuclear envelope but also to its tyrosine phosphorylation suggests that a Ca2+-activated tyrosine kinase may be involved in the specific association of annexin 11 with the nuclear envelope. Thus, in two distinct cell types we have shown that ionophore-mediated translocation of annexin 11 to the nuclear envelope is accompanied by annexin 11 tyrosine phosphorylation, whereas growth factor stimulation has no effect on either parameter. The failure of EGF and PDGF-BB to induce tyrosine phosphorylation of annexin 11 is consistent with a previous report in which it was shown that stimulation of VSMCs with PDGF-BB induced tyrosine phosphorylation of annexin 11 only when added in conjunction with peroxovanadate (21). Nevertheless, these observations raise the question why EGF and PDGF fail to reproduce the responses observed with ionomycin, given that both growth factors also mobilize Ca2+. The most likely explanation for this apparent discrepancy is that the nucleus is 'buffered' from growth factor-mediated changes in cytosolic Ca2+ but not from the effects of ionophore (28, 29).

The role of annexin 11 at the nuclear envelope during nuclear envelope breakdown and nuclear envelope reassembly is not known, but our findings illustrate a physiological situation in which annexin 11 and S100A6 might interact in vivo. The enrichment of annexin 11 at the nuclear envelope invaginations created by microtubules during nuclear envelope breakdown (24) is of particular interest because it could indicate a role for annexin 11 as a link between the nuclear envelope and the microtubules at these sites. Furthermore, several reports have established that calcium is required for nuclear envelope breakdown in eukaryotic cells (30, 31) and that spontaneous cell cycle-dependent Ca2+ transients are generated by pulsatile fluxes in inositol trisphosphate (32). Calcium is also required for lamin B degradation (33), indicating a role for Ca2+-binding proteins in these events. As a cell cycle-regulated nuclear Ca2+-binding protein, it is clearly possible that via its interaction with S100A6 annexin 11 has a role in membrane deconstruction during nuclear envelope breakdown. In contrast, the reappearance of annexin 11 during nuclear envelope reassembly may simply reflect passive transit of the protein to its notionally inactive nucleoplasmic location. If the putative annexin 11·S100A6 complex possesses such destructive activity, it would make sense that S100A6 protein levels are almost undetectable at the point in the cell cycle of nuclear envelope reassembly, thereby eliminating any possible and untimely deconstructive activity of the annexin 11·S100A6 complex.

In conclusion, we have demonstrated that elevation of intracellular Ca2+ concentration and cell cycle-dependent events are independently capable of driving the translocation of annexin 11 from the nucleoplasm to the nuclear envelope. Our observations support the idea that annexin 11 and S100A6 interact in vivo and provide evidence for a role for annexin 11 in the regulation of nuclear envelope dynamics.


    FOOTNOTES
 
* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

{ddagger} To whom correspondence should be addressed. Tel.: 020-7608-6973; Fax: 020-7608-4034; E-mail: s.moss{at}ucl.ac.uk.

1 The abbreviations used are: VSMC, vascular smooth muscle cells; LAP2, lamina-associated polypeptide 2; TRITC, tetramethylrhodamine isothiocyanate; EGF, epidermal growth factor; PDGF-BB, platelet-derived growth factor BB; PBS, phosphate-buffered saline; BSA, bovine serum albumin; GFP, green fluorescent protein; ALG-2, apoptosis-linked gene 2. Back


    ACKNOWLEDGMENTS
 
We thank Fight for Sight and the Wellcome Trust for financial support, Dr. Ying Hong for porcine VSMCs, Dr. Clare Futter for immunofluorescence secondary antibodies, Dr. Astrid Limb for human EGF, and Dr. Maryse Bailly for PDGF-BB.



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Raynal, P., and Pollard, H. B. (1994) Biochim. Biophys. Acta 1197, 63-93[Medline] [Order article via Infotrieve]
  2. Gerke, V., and Moss, S. E. (2002) Physiol. Rev. 82, 331-371[Abstract/Free Full Text]
  3. Emans, N., Gorvel, J. P., Walter, C., Gerke, V., Kellner, R., Griffiths, G., and Gruenberg, J. (1993) J. Cell Biol. 120, 1357-1369[Abstract]
  4. Merrifield, C. J., Rescher, U., Almers, W., Proust, J., Gerke, V., Sechi, A. S., and Moss, S. E. (2001) Curr. Biol. 11, 1136-1141[CrossRef][Medline] [Order article via Infotrieve]
  5. Kubista, H., Hawkins, T. E., Patel, D. R., Haigler, H. T., and Moss, S. E. (1999) Curr. Biol. 9, 1403-1406[CrossRef][Medline] [Order article via Infotrieve]
  6. Doring, V., Veretout, F., Albrecht, R., Muhlbauer, B., Schlatterer, C., Schleicher, M., and Noegel, A. A. (1995) J. Cell Sci. 108 (Pt 5), 2065-2076[Abstract/Free Full Text]
  7. Babiychuk, E. B., and Draeger, A. (2000) J. Cell Biol. 150, 1113-1124[Abstract/Free Full Text]
  8. Harder, T., Kellner, R., Parton, R. G., and Gruenberg, J. (1997) Mol. Biol. Cell 8, 533-545[Abstract]
  9. Glenney, J. R., Jr., Boudreau, M., Galyean, R., Hunter, T., and Tack, B. (1986) J. Biol. Chem. 261, 10485-10488[Abstract/Free Full Text]
  10. Donato, R. (2001) Int. J. Biochem. Cell Biol. 33, 637-668[CrossRef][Medline] [Order article via Infotrieve]
  11. Rety, S., Sopkova, J., Renouard, M., Osterloh, D., Gerke, V., Tabaries, S., Russo-Marie, F., and Lewit-Bentley, A. (1999) Nat. Struct. Biol. 6, 89-95[CrossRef][Medline] [Order article via Infotrieve]
  12. Mailliard, W. S., Haigler, H. T., and Schlaepfer, D. D. (1996) J. Biol. Chem. 271, 719-725[Abstract/Free Full Text]
  13. Rety, S., Osterloh, D., Arie, J. P., Tabaries, S., Seeman, J., Russo-Marie, F., Gerke, V., and Lewit-Bentley, A. (2000) Structure. Fold. Des 8, 175-184[Medline] [Order article via Infotrieve]
  14. Tokumitsu, H., Mizutani, A., and Hidaka, H. (1993) Arch. Biochem. Biophys. 303, 302-306[CrossRef][Medline] [Order article via Infotrieve]
  15. Minami, H., Tokumitsu, H., Mizutani, A., Watanabe, Y., Watanabe, M., and Hidaka, H. (1992) FEBS Lett. 305, 217-219[CrossRef][Medline] [Order article via Infotrieve]
  16. Seemann, J., Weber, K., and Gerke, V. (1997) FEBS Lett. 413, 185-190[CrossRef][Medline] [Order article via Infotrieve]
  17. Sudo, T., and Hidaka, H. (1999) FEBS Lett. 444, 11-14[CrossRef][Medline] [Order article via Infotrieve]
  18. Kindy, M. S., Brown, K. E., and Sonenshein, G. E. (1991) J. Cell. Biochem. 46, 345-350[Medline] [Order article via Infotrieve]
  19. Stradal, T. B., and Gimona, M. (1999) J. Biol. Chem. 274, 31593-31596[Abstract/Free Full Text]
  20. Mizutani, A., Tokumitsu, H., Kobayashi, R., and Hidaka, H. (1993) J. Biol. Chem. 268, 15517-15522[Abstract/Free Full Text]
  21. Furge, L. L., Chen, K., and Cohen, S. (1999) J. Biol. Chem. 274, 33504-33509[Abstract/Free Full Text]
  22. Mizutani, A., Watanabe, N., Kitao, T., Tokumitsu, H., and Hidaka, H. (1995) Arch. Biochem. Biophys. 318, 157-165[CrossRef][Medline] [Order article via Infotrieve]
  23. Holmer, L., and Worman, H. J. (2001) Cell Mol. Life Sci. 58, 1741-1747[Medline] [Order article via Infotrieve]
  24. Beaudouin, J., Gerlich, D., Daigle, N., Eils, R., and Ellenberg, J. (2002) Cell 108, 83-96[Medline] [Order article via Infotrieve]
  25. Satoh, H., Shibata, H., Nakano, Y., Kitaura, Y., and Maki, M. (2002) Biochem. Biophys. Res. Commun. 291, 1166-1172[CrossRef][Medline] [Order article via Infotrieve]
  26. Kitaura, Y., Matsumoto, S., Satoh, H., Hitomi, K., and Maki, M. (2001) J. Biol. Chem. 276, 14053-14058[Abstract/Free Full Text]
  27. Satoh, H., Nakano, Y., Shibata, H., and Maki, M. (2002) Biochim. Biophys. Acta 1600, 61-67[Medline] [Order article via Infotrieve]
  28. al-Mohanna, F. A., Caddy, K. W., and Bolsover, S. R. (1994) Nature 367, 745-750[CrossRef][Medline] [Order article via Infotrieve]
  29. Badminton, M. N., Kendall, J. M., Rembold, C. M., and Campbell, A. K. (1998) Cell Calcium 23, 79-86[Medline] [Order article via Infotrieve]
  30. Kao, J. P., Alderton, J. M., Tsien, R. Y., and Steinhardt, R. A. (1990) J. Cell Biol. 111, 183-196[Abstract]
  31. Wilding, M., Wright, E. M., Patel, R., Ellis-Davies, G., and Whitaker, M. (1996) J. Cell Biol. 135, 191-199[Abstract]
  32. Ciapa, B., Pesando, D., Wilding, M., and Whitaker, M. (1994) Nature 368, 875-878[CrossRef][Medline] [Order article via Infotrieve]
  33. Neamati, N., Fernandez, A., Wright, S., Kiefer, J., and McConkey, D. J. (1995) J. Immunol. 154, 3788-3795[Abstract/Free Full Text]